Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting β2-agonists

Journal of Pediatrics

Volumn 148, Issue 4, 2006, Pages 517-521

  Chipps, Bradley E ^a,b,c,d   Spahn, Joseph D ^a,b,c,d   Sorkness, Christine A ^a,b,c,d   Baitinger, Leslie ^a,b,c,d   Sutton, Laura B ^a,b,c,d   Emmett, Amanda H ^a,b,c,d   Dorinsky, Paul M ^a,b,c,d  

^a Capital Allergy and Respiratory Disease Center   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE; PLACEBO; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG;

ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXPIRATORY FLOW RATE; FORCED EXPIRATORY VOLUME; HUMAN; META ANALYSIS; PREDICTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ASTHMA; CHILD; CHILD, PRESCHOOL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE; RANDOMIZED CONTROLLED TRIALS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 33646118255     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2005.11.014     Document Type: Article

References (25)

1. Graham L. Balancing safety and efficacy in the treatment of pediatric asthma. J Allergy Clin Immunol 109 (2002) 5560-5566
2. Mannino D.M., Homa D.M., Akinbami L.J., Moorman J.E., Gwynn C., and Redd S.C. Surveillance for asthma. United States, 1980-1999. MMWR 51 (2002) 1-14
3. Fuhlbrigge A.L., Adams R.J., Guilbert T.W., Grant E., Lozano P., Janson S.L., et al. The burden of asthma in the United States. level and distribution are dependent on interpretation of the National Asthma Education and Prevention Program guidelines. Am J Respir Crit Care Med 166 (2002) 1044-1049
4. Auerbach I., Springer C., and Godfrey S. Total population survey of the frequency and severity of asthma in 17 year old boys in an urban area of Israel. Thorax 48 (1993) 139-141
5. Meng Y.Y., Leung K.M., Berkbigler D., Halbert R.J., and Legoretta A.P. Compliance with US asthma management guidelines and specialty care. a regional variation or national concern?. J Eval Clin Pract 5 (1999) 213-221
6. Colice G., Burgt J., Song J., Stampone P., and Thompson P.J. Categorizing asthma severity. Am J Respir Crit Care Med 160 (1999) 1962-1967
7. SRBI. Asthma in America Survey Executive Summary (1998). http://www.asthmainamerica.com December; available at http//:www.asthmainamerica.com.
8. National Institutes of Health, and National Heart Lung and Blood Institute. National Asthma Education and Prevention Program. Executive summary of the NAEPP expert panel report. Guidelines for the diagnosis and management of asthma: update on selected topics 2002 (2002) NIH Publication No. 02-5075. June
9. Peden D.B., Berger W.E., Noonan M.J., Thomas M.R., Hendricks V.L., Hamedan A.G., et al. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol 102 (1998) 32-38
10. Data on file. GlaxoSmithKline.
11. LaForce C.F., Pearlman D.S., Ruff M.E., Silvers W.S., Weinstein S.W., Clements D.S., et al. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma. Ann Allergy Asthma Immunol 85 (2000) 407-415
12. Weinstein S.F., Pearlman D.S., Bronsky E.A., Byrne A., Arledge T., Liddle R., et al. Efficacy of salmeterol xinafoate powder in children with chronic persistent asthma. Ann Allergy Asthma Immunol 81 (1998) 51-58
13. American Thoracic Society. Standards for the diagnosis and care of subjects with chronic obstructive pulmonary disease (COPD) and asthma. Am J Respir Crit Care Med 152 (1995) 77-120
14. Polgar G., and Promodhat V. Pulmonary function in children. techniques and standards (1971), WB Saunders, Philadelphia
15. Crapo R., Morris A., and Gardner R. Reference values for lung function tests. Respir Care 34 (1989) 626-637
16. 2-agonists alone. J Allergy Clin Immunol 112 (2003) 1088-1094
17. 1 the best measure of severity in childhood asthma?. Am J Respir Crit Care Med 169 (2004) 1-3
18. 1 is associated with risk of asthma attacks in a pediatric population. J Allergy Clin Immunol 107 (2001) 61-67
19. 1 in stable asthmatic children. Chest 96 (1989) 329-333
20. Sly P.D., Chaill P., Willet K., and Burton P. Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma. BMJ 308 (1994) 572-574
21. Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343 (2000) 1054-1063
22. Wang X., Dockery D.W., Wypij D., Gold D.R., Speizer F.E., Ware J.H., et al. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 15 (1993) 75-88
23. Sears M.R., Burrows B., Herbison G.P., Flannery E.M., and Holdaway M.D. Atopy in childhood, III. relationship with pulmonary function and airway responsiveness. Clin Exp Allergy 23 (1993) 941-948
24. Bacharier L.B., Strunk R.D., Mauger D., White D., Lemanske R.F., and Sorkness C.A. Classifying asthma severity in children. mismatch between symptoms, medication use and lung function. Am J Respir Crit Care Med 170 (2004) 426-432
25. Reddel H., Ware S., Marks G., Salome C., Jenkins C., and Woolcock A. Difference between asthma exacerbations and poor asthma control. Lancet 353 (1999) 364-369